Piper Sandler analyst Arvind Ramnani reiterates C3.ai (NYSE:AI) with a Neutral and maintains $23 price target.
Evotec Biologics Awarded Up to $49.9M Contract from the U.S. Department of Defense Under Accelerated Antibodies Program
Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX)(OTC: EVOTF)(NASDAQ: EVO) today announced that the U.S. Department of Defense ("DOD") has awarded Evotec's Seattle-based subsidiary, Just - Evotec Biologics, Inc.
